Zdrowie i gospodarka · 23/10/1997

FDA Corrects Final Rule on Selegiline Hydrochloride Tablets for Dogs

The FDA is correcting a 1997 rule that approved the use of selegiline hydrochloride tablets for dogs to control clinical signs of pituitary-dependent hyperadrenocorticism, which was inadvertently left out of the original document.